◆ NeutralENSGTHCPNTGPACS
Here's Why Ensign Group Stock Remains a Buy for Investors
Zacks Investment Research·
Ensign Group (ENSG) is benefiting from rising occupancy, patient volumes, and skilled-mix revenue growth in the post-acute care market. The company completed 25 acquisitions in H1 2026, adding 3,109 beds, and its Standard Bearer real estate segment generated $44.1 million in rental revenues. With a Zacks Rank #2 (Buy) rating and raised 2026 EPS guidance to $7.75-$7.85, ENSG faces headwinds from government reimbursement risks and rising expense growth.
Read Full Article at Zacks Investment Research →